Personalised care, digitalisation drive digital twin demand

Connected devices and remote monitoring are also creating new opportunities.

The global digital twin in healthcare market is projected to reach $18.16b by 2034, up from $2.13b in 2026.

According to Fortune Business Insights, digital twin technology is gaining traction in healthcare as providers seek more precise, data-driven, and efficient approaches to patient care.

The technology creates virtual models of patients, organs, hospital operations, and medical systems using clinical, imaging, and operational data.

These models allow healthcare providers, life sciences companies, and medical device manufacturers to test scenarios and assess potential outcomes before making clinical or operational decisions.

The growing focus on personalised treatment, predictive analytics, and operational efficiency is driving demand for digital twin platforms and related services. Companies are also investing in virtual twin applications for disease modelling, organ simulation, and hospital optimisation.

The technology is also gaining traction in personalised medicine, as providers combine clinical data, biomarkers, and real-time health information to model individual patients and disease pathways.

Healthcare digitalisation is further supporting adoption. Connected devices, electronic health records, cloud platforms, artificial intelligence, and real-time data systems are providing the infrastructure needed to deploy digital twins across hospitals, clinics, and life sciences organisations.

However, high implementation and integration costs remain a key restraint. Digital twin solutions require digital infrastructure, continuous data flows, cloud capacity, advanced analytics, and integration with electronic health records, imaging platforms, and connected devices.

Meanwhile, the increasing use of remote monitoring and connected devices presents a major growth opportunity. Wearables, smartphone-linked tools, home monitoring solutions, and connected care platforms are generating more real-time patient data that can feed digital twin models.

The market also faces challenges in moving from pilot projects to large-scale deployment. Fragmented data systems, legacy infrastructure, interoperability issues, and limited evidence across different healthcare settings can slow adoption.

Companies are pursuing regulatory approvals and new product launches to strengthen their market positions, the report said.